CTOs on the Move

Kaiser Permanente

www.medschool.kp.org

 
Kaiser Permanente is an American integrated managed care consortium, based in Oakland, California, United States, founded in 1945 by industrialist Henry J.
  • Number of Employees: 50K-100K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

Advanced Patient Advocacy

Advanced Patient Advocacy is a Richmond, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardinal Innovations

Cardinal Innovations Healthcare is the leading provider of managed care services in the U.S. Cardinal Innovations, the nations largest specialty health plan and the pioneer of a unique managed healthcare model, incorporates a community-based model of care management, a network of highly-skilled providers and local support partners to improve the health and wellness of plan members. Cardinal Innovations serves members through Medicaid, state and county-funded plans and supports a variety of initiatives for Veterans and their families through centralized call center services and other collaborative initiatives.

National Foot Care Program

National Foot Care Program is a Southfield, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Willis-Knighton Health System

Willis-Knighton Health System, headquartered in Shreveport, Louisiana, is a not-for-profit community healthcare corporation with four general acute care hospitals and affiliate relationships with several rural hospitals. It is the largest nongovernmental employer in the region, employing more than 6,500 people.

Fibrocell Science

Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.